Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Dextrose 5 And Sodium Chloride 0 45 Iv Soln

Dextrose 5% and Sodium Chloride 0.45% IV Solution

Introduction

Intravenous (IV) fluids are an essential component of clinical medicine, particularly in the management of hydration, electrolyte balance, and nutrition. Among the commonly used IV solutions is Dextrose 5% and Sodium Chloride 0.45%, also referred to as D5 1/2NS. This combination serves both as a source of fluid and calories, providing glucose along with electrolytes for patients who are unable to maintain adequate oral intake.

Composition and Physical Properties

D5 1/2NS is a sterile, non-pyrogenic solution used for intravenous administration. Each 1000 mL contains:

  • 50 grams of Dextrose (5% w/v)

  • 4.5 grams of Sodium Chloride (0.45% w/v)

This equates to approximately:

  • 170 kilocalories per liter from dextrose

  • 77 mEq of sodium and 77 mEq of chloride per liter

The solution has an osmolarity of approximately 406 mOsm/L, making it hypertonic relative to plasma. However, once the dextrose is metabolized, it behaves more like a hypotonic solution.

Pharmacological Action

D5 1/2NS acts through its two primary components:

  1. Dextrose: Provides a source of carbohydrate energy. Once administered, dextrose is rapidly metabolized into carbon dioxide and water, yielding energy. The metabolism of dextrose results in free water, which distributes across both intracellular and extracellular compartments.

  2. Sodium Chloride (0.45%): This hypotonic saline component helps maintain extracellular fluid volume and corrects mild sodium deficits. Sodium and chloride ions remain largely in the extracellular space, helping regulate osmotic pressure and acid-base balance.

Indications

D5 1/2NS is used in a wide range of clinical scenarios, including:

  • Maintenance fluid therapy in patients with normal or near-normal sodium levels

  • Postoperative fluid replacement

  • Treatment of mild to moderate dehydration

  • As a vehicle for intravenous drug administration

  • Providing calories to patients who cannot consume food orally

  • Management of gastrointestinal losses from diarrhea or vomiting

Clinical Applications

1. Maintenance Therapy: D5 1/2NS is frequently used in hospitals for maintenance IV therapy. It supplies basic fluid and energy needs without causing large shifts in electrolyte balance in most patients.

2. Postoperative Care: After surgery, patients often have increased fluid requirements due to stress-induced hormonal changes. D5 1/2NS is used to maintain perfusion and meet glucose needs.

3. Pediatric Use: In pediatric patients, D5 1/2NS may be used carefully with weight-based calculations to provide hydration and caloric intake. It is often combined with potassium depending on the electrolyte status.

4. Drug Diluent: This IV fluid is used as a diluent for the infusion of various intravenous medications, especially when some carbohydrate content is needed.

Administration Guidelines

Dosage and Rate: The volume and rate of infusion are individualized based on the patient’s age, weight, clinical condition, and ongoing fluid losses. Infusion rates must be monitored closely in:

  • Elderly patients

  • Patients with renal or cardiac dysfunction

  • Pediatric populations

Monitoring Parameters:

  • Serum electrolytes

  • Blood glucose levels

  • Fluid input and output

  • Renal function

  • Blood pressure and heart rate

Contraindications

D5 1/2NS is contraindicated or should be used cautiously in the following conditions:

  • Severe renal impairment

  • Uncontrolled diabetes mellitus

  • Hyperglycemia

  • Hypernatremia or hyperchloremia

  • Congestive heart failure (risk of fluid overload)

Precautions

Careful monitoring is required in:

  • Patients on diuretics or other medications affecting fluid balance

  • Diabetic patients (may require insulin adjustment)

  • Neonates (risk of hyperglycemia and water intoxication)

Potential Side Effects

  1. Hyperglycemia: Due to the dextrose component, especially in diabetics or stressed patients.

  2. Hyponatremia: After dextrose is metabolized, free water remains and can dilute serum sodium.

  3. Fluid Overload: Excessive administration can cause peripheral or pulmonary edema.

  4. Electrolyte Imbalance: Prolonged use without electrolyte monitoring can result in imbalances.

  5. Thrombophlebitis: Local irritation at the IV site can occur.

Special Considerations

1. In Diabetes Mellitus: Monitor blood glucose closely. D5 1/2NS should be used with insulin therapy if necessary to maintain glycemic control.

2. In Renal Impairment: The sodium load may exacerbate fluid retention or hypertension. Electrolyte and volume status must be assessed regularly.

3. In Liver Disease: Since gluconeogenesis may be impaired, use caution when providing dextrose-containing solutions.

4. In Surgery and Trauma Patients: These patients may have increased cortisol and ADH secretion, affecting fluid retention. Fluid choice must be part of an individualized fluid resuscitation strategy.

Comparison with Other IV Fluids

  • D5W (Dextrose 5% in Water): Supplies free water without electrolytes; used for hydration and as a drug diluent.

  • 0.9% Sodium Chloride (Normal Saline): Isotonic solution; better for volume resuscitation and sodium replacement.

  • Lactated Ringer’s: Balanced electrolyte solution; preferred in burn or trauma patients.

  • D5NS (Dextrose 5% in 0.9% Sodium Chloride): Hypertonic; used in specific cases requiring sodium replacement and caloric support.

Patient Education and Counseling Points

  • Inform patients receiving long-term IV fluids about the importance of electrolyte and glucose monitoring.

  • Alert for signs of fluid overload: swelling, shortness of breath, increased weight.

  • Ensure IV site is checked frequently for redness or swelling.

Conclusion

Dextrose 5% and Sodium Chloride 0.45% is a versatile intravenous fluid offering hydration, electrolyte support, and caloric supplementation. Its dual-action profile makes it suitable for a range of therapeutic situations, from routine maintenance to more complex clinical needs. However, appropriate patient selection, careful administration, and vigilant monitoring are critical to maximizing benefits and minimizing potential risks. As with any IV therapy, its use must be tailored to individual patient needs, guided by clinical judgment and laboratory monitoring.

References

  • World Health Organization. Guidelines on Fluid Therapy.

  • Intravenous Fluid Therapy in Adults in Hospital (NICE Clinical Guideline).

  • Drug monographs and hospital formularies.

  • Harrison's Principles of Internal Medicine.